GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,654.50p
   
  • Change Today:
      3.50p
  • 52 Week High: 1,711.20
  • 52 Week Low: 1,316.00
  • Currency: UK Pounds
  • Shares Issued: 4,144.88m
  • Volume: 787,225
  • Market Cap: £68,577m
  • RiskGrade: 129

Broker List

Order by
Date Broker name New Price Old price target New price target Broker change
17-Apr-24 Deutsche Buy 1,590.00p - 1,950.00p Reiteration
08-Apr-24 Barclays Equal-weight 1,620.00p - 1,725.00p Reiteration
07-Mar-24 Shore Capital Buy 1,711.20p - - Reiteration
14-Feb-24 Berenberg Bank Buy 1,668.00p 1,650.00p 1,820.00p Reiteration
28-Nov-23 Citigroup Neutral 1,411.80p - - Reiteration
29-Sep-23 JP Morgan Cazenove Underweight 1,492.00p - - Reiteration
26-Jun-23 Jefferies Hold 1,419.80p - 1,575.00p Reiteration
02-Feb-23 Credit Suisse Neutral 1,427.40p - 1,510.00p Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

GSK Market Data

Currency UK Pounds
Share Price 1,654.50p
Change Today 3.50p
% Change 0.21 %
52 Week High 1,711.20
52 Week Low 1,316.00
Volume 787,225
Shares Issued 4,144.88m
Market Cap £68,577m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
80.32% below the market average80.32% below the market average80.32% below the market average80.32% below the market average80.32% below the market average
81.13% below the sector average81.13% below the sector average81.13% below the sector average81.13% below the sector average81.13% below the sector average
Price Trend
33.37% above the market average33.37% above the market average33.37% above the market average33.37% above the market average33.37% above the market average
75.44% above the sector average75.44% above the sector average75.44% above the sector average75.44% above the sector average75.44% above the sector average
Income
43.54% above the market average43.54% above the market average43.54% above the market average43.54% above the market average43.54% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
25.34% below the market average25.34% below the market average25.34% below the market average25.34% below the market average25.34% below the market average
40.54% above the sector average40.54% above the sector average40.54% above the sector average40.54% above the sector average40.54% above the sector average

What The Brokers Say

Strong Buy 8
Buy 5
Neutral 9
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 22-Feb-24 16-Nov-23
Paid 11-Apr-24 11-Jan-24
Amount 16.00p 14.00p

Trades for 24-Apr-2024

Time Volume / Share Price
13:12 470 @ 1,654.75p
13:10 500 @ 1,654.50p
13:10 536 @ 1,654.50p
13:10 1 @ 1,654.00p
13:09 634 @ 1,654.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page